GMO Financial Gate, Inc.
Notice Regarding Partial Revision of Performance-Linked Stock Compensation Plan for Directors
A proposal to partially revise the performance-linked stock compensation plan (BBT) for directors will be submitted to the Ordinary General Meeting of Shareholders on December 18, 2026. Changes include redefining the target period, permitting a combination of stock grants and cash payments calculated at market value, removing the cap on trust contributions, and enhancing future flexibility in stock compensation design to better share stock price downside risk.
Key Figures
- Up to 6,000 points per fiscal year as the maximum number of points
- The ratio of stock grants to cash payments for directors meeting beneficiary requirements will be determined by a specified ratio
- Trust period will continue after revision; if additional contributions are made, remaining shares will be used as the source
AI要約
Key Points of the Revision
GMO Financial Gate, Inc. will partially revise its director compensation plan using a stock delivery trust (BBT), proposing to the shareholders to redefine the target period and to allow a portion of stock grants to be converted into cash payments calculated at market value. The proposal also includes removing the upper limit on the amount of funds contributed as trust assets. The objective is to share not only upside but also downside stock price risk and to promote medium- to long-term corporate value enhancement.
Impact and Outlook
After the revision, directors who meet beneficiary requirements will receive stock grants based on confirmed point totals, and a certain proportion may be converted into cash payments. The trust period will continue to be set, and future disclosures will address whether additional contributions will be made and how remaining shares will be handled. Overall, the revision is expected to increase flexibility in executive compensation design and strengthen alignment with shareholder value, although specific contribution amounts and post-revision figures are currently unknown.
GMO Financial Gate, Inc.
Company overview · Stock price · Financial data · All IR